dihexa peptide pills (5mg/capsule), 60 Capsules Dihexa Capsules 30 x 10mg

Stricker RB, Winger EE

Research has shown KPV: Reduces intestinal inflammation Supports gut barrier function Modulates the immune response in inflammatory bowel conditions For long COVID patients with significant gut dysfunction and gut-driven systemic inflammation, KPV offers a targeted, well-tolerated option for reducing the gut-immune inflammatory burden

In research models, any induced discomfort is managed by the study protocol

The main clinical use being investigated is obesity treatment, either as cagrilintide alone or in the fixed-dose cagrilintide and semaglutide combination known as CagriSema

Board Certification requires extensive specialty-specific training and ongoing education to stay up to date on the most recent advances in pain medicine